Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intravenous IgG in Guillain-Barré syndrome.

× No keyword cloud information.

7 in total

1. A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value.

Authors: J B Winer; R A Hughes; C Osmond
Journal: J Neurol Neurosurg Psychiatry Date: 1988-05 Impact factor: 10.154

Review 2. Acute neuromuscular respiratory paralysis.

Authors: R A Hughes; D Bihari
Journal: J Neurol Neurosurg Psychiatry Date: 1993-04 Impact factor: 10.154

3. Natural history and treatment effects in Guillain-Barré syndrome: a multicentre study.

Authors: R Korinthenberg; J S Mönting
Journal: Arch Dis Child Date: 1996-04 Impact factor: 3.791

4. Campylobacter jejuni infection and Guillain-Barré syndrome.

Authors: J H Rees; S E Soudain; N A Gregson; R A Hughes
Journal: N Engl J Med Date: 1995-11-23 Impact factor: 91.245

5. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome.

Authors: J W Griffin; C Y Li; C Macko; T W Ho; S T Hsieh; P Xue; F A Wang; D R Cornblath; G M McKhann; A K Asbury
Journal: J Neurocytol Date: 1996-01

6. Intravenous immunoglobulin treatment in children with Guillain-Barre syndrome.

Authors: N Gürses; S Uysal; F Cetinkaya; I Işlek; A G Kalayci
Journal: Scand J Infect Dis Date: 1995

Review 7. Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases.

Authors: J W Griffin; C Y Li; T W Ho; P Xue; C Macko; C Y Gao; C Yang; M Tian; B Mishu; D R Cornblath
Journal: Brain Date: 1995-06 Impact factor: 13.501

7 in total

4 in total

Review 1. Clinical utility of autoantibodies in Guillain-Barre syndrome and its variants.

Authors: J W Terryberry; Y Shoenfeld; J B Peter
Journal: Clin Rev Allergy Immunol Date: 1998 Impact factor: 8.667

2. Intravenous immunoglobulin in the Guillain-Barré syndrome. May cause severe adverse skin reactions.

Authors: H H Hamdalla; C H Hawkes; E G Spokes; J M Bamford; P J Goulding
Journal: BMJ Date: 1996-11-30

3. Intravenous immunoglobulin in the Guillain-Barré syndrome. Products with low IgA content may be used in patients with total IgA deficiency.

Authors: S Misbah
Journal: BMJ Date: 1996-11-30

4. Weakness in pregnancy - expect the unexpected.

Authors: S Furara; M Maw; F Khan; K Powell
Journal: Obstet Med Date: 2008-12-01

4 in total